Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Current options for the treatment of optic neuritis.
An uncommon cause of compressive myelopathy misdiagnosed as transverse myelitis.
Acute disseminated encephalomyelitis in Siriraj Hospital: clinical manifestations and short-term outcome.
[Clinical significance of T-regulatory cells in multiple sclerosis.]
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Evaluation of new immunological targets in neuromyelitis optica.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet.
[Recent prognosis on etiology and pathophysiology of multiple sclerosis].
Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.
Clinical characteristics of optic neuritis in koreans greater than 50 years of age.
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations.
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data.]
Correction: Combined Acquisition Technique (CAT) for Neuroimaging of Multiple Sclerosis at Low Specific Absorption Rates (SAR).
Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Concurrent motor and cognitive function in multiple sclerosis: a motor overflow and motor stability study.
Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
Mitochondrial and nuclear genes as the cause of complex I deficiency.
Simultaneous optic neuropathy and osmotic demyelinating syndrome in hyperemesis gravidarum.
Effect of Smoking Cessation on Multiple Sclerosis Prognosis.
Pages
« first
‹ previous
…
277
278
279
280
281
282
283
284
285
…
next ›
last »